CAJ | 학술논문

目的采用喷雾干燥法制备胰岛素吸入粉雾剂,对吸入粉雾剂体外沉降性质进行考察,并对其吸收促进剂在大鼠体内的药效学进行初步研究.方法采用中国药典(2000版)附录XH的装置测定粉末的体外有效部位沉积量,以葡糖氧化酶法(GOD-PAP法)测定大鼠的血糖浓度来评价其降血糖效果.结果喷雾干燥法制得的胰岛素吸收粉雾剂沉积量在各湿度下均大于40%,在气流量≥18 L·min-1的情况下其有效部位沉积量变化不大.8mmol·L-1/dose牛黄胆酸钠[PA=59.91%,Cnadir=(33±6)%]和10 mmol·L-1/dose去氧胆酸钠[PA=47.46%,Cnadir=(32±7)%]对胰岛素肺部吸收促进作用明显.而1%辛酸钠、1%十二烷基硫酸钠、250μg/dose卵磷脂和10mmol·L-1/dose EDTA并未显示明显效果.结论制得的胰岛素吸收粉雾剂沉积量受湿度影响小,环境湿度依赖性和吸气流量依赖性小.8 mmol·L-1/dose牛黄胆酸钠和10 mmol·L-1/dose去氧胆酸钠可有效促进胰岛素干粉吸入剂的降血糖效果.
목적채용분무간조법제비이도소흡입분무제,대흡입분무제체외침강성질진행고찰,병대기흡수촉진제재대서체내적약효학진행초보연구.방법채용중국약전(2000판)부록XH적장치측정분말적체외유효부위침적량,이포당양화매법(GOD-PAP법)측정대서적혈당농도래평개기강혈당효과.결과분무간조법제득적이도소흡수분무제침적량재각습도하균대우40%,재기류량≥18 L·min-1적정황하기유효부위침적량변화불대.8mmol·L-1/dose우황담산납[PA=59.91%,Cnadir=(33±6)%]화10 mmol·L-1/dose거양담산납[PA=47.46%,Cnadir=(32±7)%]대이도소폐부흡수촉진작용명현.이1%신산납、1%십이완기류산납、250μg/dose란린지화10mmol·L-1/dose EDTA병미현시명현효과.결론제득적이도소흡수분무제침적량수습도영향소,배경습도의뢰성화흡기류량의뢰성소.8 mmol·L-1/dose우황담산납화10 mmol·L-1/dose거양담산납가유효촉진이도소간분흡입제적강혈당효과.
Aim To prepare insulin powder for inhalation by spray-drying technology, determine the deposition of the insulin powder formulation in vitro and preliminarily investigate hypoglycemic response of the dry powder with/without absorption promoters. Methods The depositions of the insulin powder for inhalation were determined by the China Pharmacopoeia 2000 version addenda XH and hypoglycemic effects were evaluated by testing serum glucose with glucose oxidase-peroxidase (GOD-PAP) method.Results The depositions of the spray-dried insulin powder for inhalation were more than 40% under significantly greater decline in blood glucose levels, while coadministration with 1% sodium caprylate, 1%effect ( P ＞ 0. 05 ). Conclusion Insulin powder for inhalation was relatively stable under various humidity pulmonary route.